 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RegeneRx Biopharmaceuticals, Inc. engages in the development of a novel therapeutic peptide, Thymosin beta 4 for tissue and organ protection, repair, and regeneration. Its product pipeline includes RGN-259, RGN-352, and RGN-137. The company was founded by Allan L. Goldstein on May 13, 1982 and is headquartered in Rockville, MD.

Watchers	216
52-Wk Low	$0.013
52-Wk High	$18.99

Market Cap	$2.53M
Volume (M)	430,126.00
52-Wk High	$18.99
52-Wk Low	$0.013

Current Price	$0.0095
Prev Close	$0.017
Open	$0.02
Dividend Yield	0.00%
50-Day Moving Average	$0.8847
Beta	0.27
Avg. Volume	97,145.10
PE Ratio	-1.44

52-Week High	$18.99
52-Week Low	$0.013
Market Capitalization	$2.53M
EPS	-$0.0118
Price to Book	-0.65
Revenue Per Employee	$38,380.50
Enterprise Value/EBITDA	-12.08

RGRX Regenerx Biopharmaceuticals Inc.

About

Feed

News

Fundamentals